Biex To Educate Clinicians/Payers On SalEst Cost Benefits Prior To Roll-Out
This article was originally published in The Gray Sheet
Executive Summary
Biex' 40-member sales and clinical support organization is preparing for the launch of the SalEst salivary estriol test in the U.S. with a six-week education program aimed at physicians and payers on the utility of the product as an aid in identifying women at risk for preterm labor and delivery.
You may also be interested in...
FDA Approval To Reimbursement A Challenge For Start-Ups – Biex Founder
Biex, Inc. plans to relaunch its salivary estriol test for detecting pre-term labor (PTL) with a retooled business strategy after experiencing difficulties in its initial attempts to gain sufficient reimbursement coverage
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.